RTW Biotech Opportunities commits a further $42.8 million to buybacks

Healthcare trust RTW Biotech Opportunities (LON:RTW) has expanded its capital allocation framework with a further $42.8 million for share buybacks. The fund has already returned $42.3 million of the $45 million buyback target announced three years ago. In addition, it has repurchased 7.2 million shares in the year to 5 November. Further $42.8 million for … Continue reading RTW Biotech Opportunities commits a further $42.8 million to buybacks